Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   Adeno-associated viral vector mediated expression of broadly-neutralizing antibodies against HIV - hitting a fast-moving target
  2. Sherpa,Chringma; Le Grice,Stuart
  3. Current HIV research. 2020, Feb 10; 18(2): 114-131.
  1. 2.   Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation
  2. Lee, M. H.; Lahusen, T.; Wang, R. H.; Xiao, C.; Xu, X.; Hwang, Y. S.; He, W. W.; Shi, Y.; Deng, C. X.
  3. Oncogene. 2012, Jan; 31(1): 116-127.
  1. 3.   Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen
  2. Winstone, N.; Wilson, A. J.; Morrow, G.; Boggiano, C.; Chiuchiolo, M. J.; Lopez, M.; Kemelman, M.; Ginsberg, A. A.; Mullen, K.; Coleman, J. W.; Wu, C. D.; Narpala, S.; Ouellette, I.; Dean, H. J.; Lin, F.; Sardesai, N. Y.; Cassamasa, H.; McBride, D.; Felber, B. K.; Pavlakis, G. N.; Schultz, A.; Hudgens, M. G.; King, C. R.; Zamb, T. J.; Parks, C. L.; McDermott, A. B.
  3. Journal of Virology. 2011, Sep; 85(18): 9578-9587.
  1. 4.   A New Generation of Serotype Chimeric Infectivity-Enhanced Conditionally Replicative Adenovirals: The Safety Profile of Ad5/3-Delta 24 in Advance of a Phase I Clinical Trial in Ovarian Cancer Patients
  2. Kim, K. H.; Ryan, M. J.; Estep, J. E.; Miniard, B. M.; Rudge, T. L.; Peggins, J. O.; Broadt, T. L.; Wang, M. H.; Preuss, M. A.; Siegal, G. P.; Hemminki, A.; Harris, R. D.; Aurigemma, R.; Curiel, D. T.; Alvarez, R. D.
  3. Human Gene Therapy. 2011, Jul; 22(7): 821-828.
  1. 5.   A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases
  2. Kimball, K. J.; Preuss, M. A.; Barnes, M. N.; Wang, M. H.; Siegal, G. P.; Wan, W.; Kuo, H. C.; Saddekni, S.; Stockard, C. R.; Grizzle, W. E.; Harris, R. D.; Aurigemma, R.; Curiel, D. T.; Alvarez, R. D.
  3. Clinical Cancer Research. 2010, Nov; 16(21): 5277-5287.
  1. 6.   Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
  2. Garg, H.; Salcedo, R.; Trinchieri, G.; Blumenthal, R.
  3. Cancer Gene Therapy. 2010, Mar; 17(3): 155-163.
  1. 7.   Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5
  2. Abe, S.; Okuda, K.; Ura, T.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Mizuguchi, H.; Klinman, D.; Shimada, M.
  3. Journal of Gene Medicine. 2009 11(7): 570-579.
  1. 8.   Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963
  2. Thorne, S. H.; Hwang, T. H. H.; O'Gorman, W. E.; Bartlett, D. L.; Sei, S.; Kanji, F.; Brown, C.; Werier, J.; Cho, J. H.; Lee, D. E.; Wang, Y.; Bell, J.; Kirn, D. H.
  3. Journal of Clinical Investigation. 2007, Nov; 117(11): 3350-3358.
  1. 9.   Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Delta 24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer
  2. Page, J. G.; Tian, B. H.; Schweikart, K.; Tomaszewski, J.; Harris, R.; Broadt, T.; Polley-Nelson, J.; Noker, P. E.; Wang, M. H.; Makhija, S.; Aurigemma, R.; Curiel, D. T.; Alvarez, R. D.
  3. American Journal of Obstetrics and Gynecology. 2007, Apr; 196(4):
  1. 10.   Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus
  2. Kaur, A.; Sanford, H. B.; Garry, D.; Lang, S.; Klumpp, S. A.; Watanabe, D.; Bronson, R. T.; Lifson, J. D.; Rosati, M.; Pavlakis, G. N.; Felber, B. K.; Knipe, D. M.; Desrosiers, R. C.
  3. Virology. 2007, Jan; 357(2): 199-214.
  1. 11.   Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques
  2. Gomez-Roman, V. R.; Grimes, G. J.; Potti, G. K.; Peng, B.; Demberg, T.; Gravlin, L.; Treece, J.; Pal, R.; Lee, E. M.; Alvord, W. G.; Markham, P. D.; Robert-Guroff, M.
  3. Vaccine. 2006, Jun; 24(23): 5064-5072.
  1. 12.   De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses
  2. Wang, D. H.; Schmaljohn, A. L.; Raja, N. U.; Trubey, C. M.; Juompan, L. Y.; Luo, M.; Deitz, S. B.; Yu, H.; Woraratanadharm, J.; Holman, D. H.; Moore, K. M.; Swain, B. M.; Pratt, W. D.; Dong, J. Y.
  3. Vaccine. 2006, Apr; 24(15): 2975-2986.
  1. 13.   Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice
  2. Jin, H.; Kim, T. H.; Hwang, S. K.; Chang, S. H.; Kim, H. W.; Anderson, H. K.; Lee, H. W.; Lee, K. H.; Colburn, N. H.; Yang, H. S.; Cho, M. H.; Cho, C. S.
  3. Molecular Cancer Therapeutics. 2006, Apr; 5(4): 1041-1049.
  1. 14.   Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag
  2. Zhao, J.; Voltan, R.; Peng, B.; vis-Warren, A.; Kalyanaraman, V. S.; Alvord, W. G.; Aldrich, K.; Bernasconi, D.; Butto, S.; Cafaro, A.; Ensoli, B.; Robert-Guroff, M.
  3. Virology. 2005, NOV 10; 342(1): 1-12.
  1. 15.   Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following Ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE
  2. Pinczewski, J.; Zhao, J.; Malkevitch, N.; Patterson, L. J.; Aldrich, K.; Alvord, W. G.; Robert-Guroff, M.
  3. Viral Immunology. 2005, SPR; 18(1): 236-243.
  1. 16.   Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice
  2. Kim, H. W.; Park, I. K.; Cho, C. S.; Lee, K. H.; Beck, G. R.; Colburn, N. H.; Cho, M. H.
  3. Cancer Research. 2004, NOV 1; 64(21): 7971-7976.
  1. 17.   Adenovirus production and recovery using a wave bioreactor
  2. Ekstrom, D.; Cheng, W.; Andersson, R.; Mitra, G.; Zhu, J. W.
  3. Abstracts of Papers of the American Chemical Society. 2004, MAR 28; 227(097-BIOT, Part 1): U202-U202.
  1. 18.   Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway
  2. Chen, S. Y.; Lin, J. R. V.; Darbha, R.; Lin, P. P.; Liu, T. Y.; Chen, Y. M. A.
  3. Cancer Research. 2004 64(10): 3617-3623.
  1. 19.   A simian replication-defective vaccine to HIV-1 gag
  2. Fitzgerald, J. C.; Gao, G. P.; Reyes-Sandoval, A.; Pavlakis, G. N.; Xiang, Z. Q.; Wlazlo, A. P.; Giles-Davis, W.; Wilson, J. M.; Ertl, H. C. J.
  3. Journal of Immunology. 2003 170(3): 1416-1422.
  1. 20.   Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants
  2. Zhao, J.; Lou, Y. M.; Pinczewski, J.; Malkevitch, N.; Aldrich, K.; Kalyanaraman, V. S.; Venzon, D.; Peng, B.; Patterson, L. J.; Edghill-Smith, Y.; Woodward, R.; Pavlakis, G. N.; Robert-Guroff, M.
  3. Vaccine. 2003 21(25-26): 4022-4035.
  1. 21.   Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120
  2. Patterson, L. J.; Malkevitch, N.; Pinczewski, J.; Venzon, D.; Lou, Y. M.; Peng, B.; Munch, C.; Leonard, M.; Richardson, E.; Aldrich, K.; Kalyanaraman, V. S.; Pavlakis, G. N.; Robert-Guroff, M.
  3. Journal of Virology. 2003 77(16): 8607-8620.
  1. 22.   Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIVmac251 challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen
  2. Zhao, J.; Pinczewski, J.; Gomez-Roman, V. R.; Venzon, D.; Kalyanaraman, V. S.; Markham, P. D.; Aldrich, K.; Moake, M.; Montefiori, D. C.; Lou, Y. M.; Pavlakis, G. N.; Robert-Guroff, M.
  3. Journal of Virology. 2003 77(15): 8354-8365.
  1. 23.   Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions
  2. Lyakh, L. A.; Koski, G. K.; Young, H. A.; Spence, S. E.; Cohen, P. A.; Rice, N. R.
  3. Blood. 2002 99(2): 600-608.
  1. 24.   Insertion of HIV-1 genes into Ad4 Delta E3 vector abrogates increased pathogenesis in cotton rats due to E3 deletion
  2. Patterson, L. J.; Prince, G. A.; Richardson, E.; Alvord, W. G.; Kalyan, N.; Robert-Guroff, M.
  3. Virology. 2002 292(1): 107-113.
  1. 25.   Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBP beta) - Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBP beta
  2. Guo, S. D.; Cichy, S. B.; He, X. W.; Yang, Q. Y.; Ragl, M.; Ghosh, A. K.; Johnson, P. F.; Unterman, T. G.
  3. Journal of Biological Chemistry. 2001 276(11): 8516-8523.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel